| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner
1 company
5am Partners VII, LLC is 10% Owner at SKYE.
Our model assigns 5am Partners VII, LLC a strong insider score of 81/100, based on 4 past trades. Over a 12-month horizon, all 4 of those trades were profitable, with an average 12-month return of +61.4%.
5am Partners VII, LLC has 7 Form 4 filings on record from January 2024 to September 2026, all as 10% Owner at Skye Bioscience (SKYE), 2024–2026.
The 27 reported transactions were 25 open-market sales and 2 open-market purchases.
Counted by filing, the open-market trades come to 2 purchases worth about $16.5M and 5 sales worth about $3.0M.
The largest open-market purchase was 5,206,074 shares of SKYE at an average $2.31 on January 31, 2024, about $12.0M.
The largest open-market sale was 266,337 shares of SKYE at an average $6.57 on September 13, 2024, about $1.8M. Twelve months later SKYE was down 29%.
None of the 5 sales since April 2023 was marked as made under a Rule 10b5-1 trading plan.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | SKYE Skye Bioscience, Inc. | 10% Owner | Sell | 148,079 | $1.62 | $239,555.19 | -100% | - | - | |
| Sep 16, 2026 | SKYE Skye Bioscience, Inc. | 10% Owner | Sell | 33,892 | $1.91 | $64,733.72 | -85.8% | - | - | |
| Aug 20, 2026 | SKYE Skye Bioscience, Inc. | 10% Owner | Sell | 375,840 | $0.37 | $140,313.00 | -3.9% | - | - | |
| Aug 22, 2025 | SKYE Skye Bioscience, Inc. | 10% Owner | Sell | 231,405 | $3.46 | $800,548.50 | -80.1% | -62.0% | -91.5% | |
| Sep 13, 2024 | SKYE Skye Bioscience, Inc. | - | Sell | 266,337 | $6.57 | $1,750,352.22 | -80.1% | -44.2% | -29.2% | |
| Mar 13, 2024 | SKYE Skye Bioscience, Inc. | 10% Owner | Buy | 450,000 | $10.00 | $4,500,000.00 | +5.7% | - | - | |
| Jan 31, 2024 | SKYE Skye Bioscience, Inc. | 10% Owner | Buy | 5,206,074 | $2.31 | $12,026,030.94 | +190.2% | - | - |